Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 19, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, May 18, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Umer Raffat Upgraded (TEVA) to Buy on, May 18th, 2023
Umer Raffat of Evercore ISI Group, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Buy on, May 18th, 2023.
Umer has made no other calls on TEVA in the last 4 months.
There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Umer's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Glen Santangelo of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $12 on, Thursday, January 19th, 2023
These are the ratings of the 2 analyists that currently disagree with Umer
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $11 on, Thursday, May 11th, 2023
- Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $14 on, Thursday, February 9th, 2023
